Literature DB >> 34257067

Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.

Andrew Turner1,2, Anne Scott3, Jeremy Horwood4,3, Chris Salisbury4,3, Rachel Denholm3,5, Lauren J Scott4,2, Geeta Iyer6, John MacLeod4,3, Mairead Murphy3.   

Abstract

BACKGROUND: In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. AIM: To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. DESIGN &
SETTING: Qualitative interview study in general practices in Bristol, North Somerset and South Gloucestershire.
METHOD: Longitudinal semi-structured interviews with clinical and managerial practice staff at four timepoints between May and July 2020.
RESULTS: Practices worked flexibly within general national guidance to determine when face-to-face contact with patients was necessary, influenced by knowledge of the patient, experience, and practice resilience. For example, practices prioritised patients according to clinical need using face-to-face contact to resolve clinician uncertainty or provide adequate reassurance to patients. To make face-to-face contact as safe as possible and keep patients separated, practices introduced a heterogeneous range of measures that exploited features of their indoor and outdoor spaces and altered their appointment processes. As national restrictions eased in June and July, the number and proportion of patients seen face-to-face generally increased. However, the reconfiguration of buildings and processes reduced the available capacity and put increased pressure on practices.
CONCLUSION: Practices responded rapidly and creatively to the initial lockdown restrictions. The variety of ways practices organised face-to-face contact to minimise infection highlights the need for flexibility in guidance.
Copyright © 2021, The Authors.

Entities:  

Keywords:  COVID-19; consultations; face-to-face consulting; general practitioners

Year:  2021        PMID: 34257067     DOI: 10.3399/BJGPO.2021.0036

Source DB:  PubMed          Journal:  BJGP Open        ISSN: 2398-3795


  6 in total

1.  Primary care practice and cancer suspicion during the first three COVID-19 lockdowns in the UK: a qualitative study.

Authors:  Claire Friedemann Smith; Brian D Nicholson; Yasemin Hirst; Susannah Fleming; Clare R Bankhead
Journal:  Br J Gen Pract       Date:  2022-07-22       Impact factor: 6.302

Review 2.  Telemedicine and virtual respiratory care in the era of COVID-19.

Authors:  Hilary Pinnock; Phyllis Murphie; Ioannis Vogiatzis; Vitalii Poberezhets
Journal:  ERJ Open Res       Date:  2022-07-25

3.  Public perception of NHS general practice during the first six months of the COVID-19 pandemic in England.

Authors:  Lorna J Duncan; Kelly F D Cheng
Journal:  F1000Res       Date:  2021-04-08

4.  Conducting rapid qualitative interview research during the COVID-19 pandemic-Reflections on methodological choices.

Authors:  Marta Wanat; Aleksandra J Borek; Caitlin Pilbeam; Sibyl Anthierens; Sarah Tonkin-Crine
Journal:  Front Sociol       Date:  2022-08-11

5.  The effect of the COVID-19 pandemic on primary care physicians in Israel, with comparison to an international cohort: a cross-sectional study.

Authors:  Limor Adler; Shlomo Vinker; Anthony D Heymann; Esther Van Poel; Sara Willems; Galia Zacay
Journal:  Isr J Health Policy Res       Date:  2022-09-20

6.  The experience of conducting collaborative and intensive pragmatic qualitative (CLIP-Q) research to support rapid public health and healthcare innovation.

Authors:  Jeremy Horwood; Christalla Pithara; Ava Lorenc; Joanna M Kesten; Mairead Murphy; Andrew Turner; Michelle Farr; Jon Banks; Sabi Redwood; Helen Lambert; Jenny L Donovan
Journal:  Front Sociol       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.